NextCure, Inc. (NXTC)
NASDAQ: NXTC · IEX Real-Time Price · USD
1.690
+0.010 (0.60%)
At close: Jul 19, 2024, 12:00 AM
1.790
+0.100 (5.92%)
Pre-market: Jul 20, 2024, 9:26 AM EDT
NextCure Employees
NextCure had 82 employees as of December 31, 2023. The number of employees decreased by 17 or -17.17% compared to the previous year.
Employees
82
Change (1Y)
-17
Growth (1Y)
-17.17%
Revenue / Employee
n/a
Profits / Employee
-$777,244
Market Cap
47.27M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Bionano Genomics | 344 |
Apyx Medical | 252 |
Vicarious Surgical | 131 |
DURECT | 58 |
Kezar Life Sciences | 58 |
Modular Medical | 40 |
Elicio Therapeutics | 32 |
Protara Therapeutics | 27 |
NXTC News
- 4 weeks ago - NextCure to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference - GlobeNewsWire
- 7 weeks ago - NextCure Presents Phase 1b Data on NC410 and Pembrolizumab Combination at ASCO 2024 - GlobeNewsWire
- 2 months ago - NextCure Provides Business Update and Reports First Quarter 2024 Financial Results - GlobeNewsWire
- 3 months ago - NextCure to Present Phase 1b Data of NC410 in Combination with Pembrolizumab at ASCO 2024 - GlobeNewsWire
- 3 months ago - NextCure and LCB Present Preclinical Data on B7-H4 Antibody Drug Conjugate at AACR 2024 - GlobeNewsWire
- 3 months ago - NextCure Appoints Dr. Rakesh Dixit to Scientific Advisory Board - GlobeNewsWire
- 3 months ago - NextCure to Present at 23rd Annual Needham Virtual Healthcare Conference - GlobeNewsWire
- 4 months ago - NextCure Provides Business Update and Reports Full Year 2023 Financial Results - GlobeNewsWire